Serina Therapeutics (SER) Share-based Compensation (2017 - 2025)

Serina Therapeutics has disclosed Share-based Compensation across 9 years of filings, most recently posting $948000.0 for Q4 2025.

• In Q4 2025, Share-based Compensation changed N/A year-over-year to $948000.0; the TTM figure through Dec 2025 stood at $3.8 million (down 89.58% YoY), while the FY2025 annual figure was $3.8 million, down 89.58% from the prior year.
• Share-based Compensation came in at $948000.0 for Q4 2025 at Serina Therapeutics, down from $999000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $36.4 million in Q1 2024 to a low of $114000.0 in Q4 2022.
• Average Share-based Compensation over 5 years is $4.0 million, with a median of $999000.0 recorded in 2025.
• Year-over-year, Share-based Compensation surged 2050.21% in 2023 and slumped 97.37% in 2025.
• Over 5 years, Share-based Compensation stood at $263000.0 in 2021, then plunged by 56.65% to $114000.0 in 2022, then jumped by 4385.09% to $5.1 million in 2023, then tumbled by 67.7% to $1.7 million in 2024, then plunged by 42.6% to $948000.0 in 2025.
• Per Business Quant data, the three most recent Share-based Compensation figures were $948000.0 in Q4 2025, $999000.0 in Q3 2025, and $890000.0 in Q2 2025.